Listen "Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25"
Episode Synopsis
In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients.
More episodes of the podcast Becker Business Minute Podcast
A Rebound Day 11-10-25
10/11/2025
Surgery Partners Drops 24% 11-10-25
10/11/2025
5 Quick Notes for This Weekend 11-8-25
08/11/2025
My Own Government Shutdown 11-7-25
07/11/2025
8 Stories Defining This Week 11-7-25
07/11/2025
4 Stocks Getting Crushed 11-7-25
07/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.